Gary S. Mather
Corporate Officer/Principal chez MYREXIS, INC.
Provenance du réseau au premier degré de Gary S. Mather
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Financial Conglomerates | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Gary S. Mather via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| MYRIAD GENETICS, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal President Chairman General Counsel Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Utah | College/University | Graduate Degree Doctorate Degree | |
Xstelos Holdings, Inc.
 Xstelos Holdings, Inc. Financial ConglomeratesFinance Xstelos Holdings, Inc. operates as a development stage company which is currently seeking funding from other sources, including, but not limited to, contribution by others to joint ventures and other collaborative or licensing arrangements for the development, testing, manufacturing and marketing of products currently under development, and sales of debt or equity securities. The company is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Masters Business Admin | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | President Director of Finance/CFO | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Biofire Diagnostics, Inc.
 Biofire Diagnostics, Inc. Electronic Production EquipmentElectronic Technology Biofire Diagnostics, Inc. manufactures, markets and sales of the film array system. Its FilmArray is an FDA-cleared multiplex PCR system that integrates sample preparation, amplification, detection and analysis. The firm has three FDA cleared panels the respiratory Panel, the blood culture identification panel, and the Gastrointestinal Panel. The company was founded by Randy Rasmussen, Carl Wittwer and Kirk Ririe in 1990 and is headquartered in Salt Lake City, UT. | Electronic Production Equipment | Director of Finance/CFO Director of Finance/CFO | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Medical Specialties | Director/Board Member | |
| ANEBULO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
| Rio Grande Renewables LLC | Founder | ||
| ORCHESTRA BIOMED HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
| Cytovia Holdings, Inc. | Director/Board Member | ||
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
| EQRX, INC. | Pharmaceuticals: Major | Founder | |
Rhapsody Biologics, Inc.
 Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA. | Biotechnology | Director/Board Member | |
SevenOaks Biosystems LLC
 SevenOaks Biosystems LLC Medical SpecialtiesHealth Technology Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016. | Medical Specialties | Director/Board Member | |
Deciduous Therapeutics, Inc.
 Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
Pillar Biosciences, Inc.
 Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA. | Pharmaceuticals: Major | Director/Board Member | |
| University of Bristol | College/University | Graduate Degree | |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member | |
| University of Detroit Mercy | College/University | Masters Business Admin | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
| FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| MIND MEDICINE (MINDMED) INC. | Pharmaceuticals: Major | Director/Board Member | |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Miscellaneous Commercial Services | Director/Board Member | |
| Futurepharm LLC | President | ||
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chairman | |
| The University of Edinburgh | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 44 |
| Royaume-Uni | 5 |
| Canada | 4 |
Sectorielle
| Health Technology | 36 |
| Consumer Services | 7 |
| Finance | 4 |
| Retail Trade | 2 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 137 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 49 |
| President | 28 |
| Chairman | 22 |
Relations les plus connectées
| Insiders | |
|---|---|
| Dennis Langer | 40 |
| Steven Scheiwe | 33 |
| Timothy Franson | 26 |
| Robert M. Forrester | 25 |
| David Gryska | 20 |
| Jason Aryeh | 18 |
| Michael Cooper Pearce | 14 |
| Richard B. Brewer | 14 |
| Mark Brian Anderson | 11 |
| John Henderson | 10 |
| Jonathan Couchman | 10 |
| Robert J. Lollini | 9 |
| Brian Dowd | 9 |
| Adrian N. Hobden | 8 |
| Gerald P. Belle | 7 |
- Bourse
- Insiders
- Gary S. Mather
- Connexions Sociétés
